voriconazole has been researched along with Infectious Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Andes, DR; Cattaneo, D; Christian, R; Davis, MR; Johnson, MD; Lewis, RE; McCreary, EK; Narayanan, N; Watt, KM; Wiederhold, NP | 1 |
Chatelut, E; Florent, A; Gandia, P; Houin, G; Seraissol, P | 1 |
Basu, S; Kumar, A; Tilak, R | 1 |
Buchheidt, D; Christopeit, M; Hähnel, S; Heinz, W; Maschmeyer, G; Meyding-Lamadé, U; Panse, J; Penack, O; Ruhnke, M; Schalk, E; Schmidt-Hieber, M; Schwartz, S; Silling, G; Wolf, HH | 1 |
1 review(s) available for voriconazole and Infectious Diseases
Article | Year |
---|---|
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
Topics: Antifungal Agents; Communicable Diseases; Drug Monitoring; Humans; Mycoses; Pharmacists; Triazoles; Voriconazole | 2023 |
3 other study(ies) available for voriconazole and Infectious Diseases
Article | Year |
---|---|
Determination of plasma unbound fraction of voriconazole in patients treated with a prophylactic or a curative treatment.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Communicable Diseases; Drug Monitoring; Female; Humans; Male; Middle Aged; Pre-Exposure Prophylaxis; Protein Binding; Treatment Outcome; Voriconazole; Young Adult | 2014 |
Multidrug-resistant Trichosporon: an unusual fungal sepsis in preterm neonates.
Topics: Amphotericin B; Antifungal Agents; Communicable Diseases; Drug Administration Schedule; Drug Resistance, Fungal; Fatal Outcome; Guideline Adherence; Humans; Infant; Infant, Newborn; Infant, Premature; Sepsis; Trichosporon; Trichosporonosis; Voriconazole | 2015 |
CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Topics: Central Nervous System; Communicable Diseases; Germany; Guidelines as Topic; Hematologic Diseases; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Medical Oncology; Toxoplasma; Voriconazole | 2016 |